STAT

2018 in limericks: The highs and lows from the life sciences

What a year it's been in the life sciences: CRISPR babies and IPOs galore, high-priced CAR-Ts and gene therapies. We remember it all with the 2018 edition of our year…

It’s been an eventful year in the life sciences, from the struggles of IBM Watson, to China’s twin CRISPR surprise, to a flurry of IPOs, to catching a serial killer with.)

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readPsychology
‘Please Know You’re Not Alone’: For Dementia Caregivers, A Place To Share With Strangers — And Be Honest
It was an indescribable relief to finally connect with someone who understood what, exactly, it was like.
STAT3 min readScience
Lasker Award Recipient Had Retracted Some Of His Work — a Sign Of Strength, Not Sloppiness
While retractions are usually seen as black marks on a career, a signal of sloppy or dishonest research, sometimes the opposite is true.
STAT4 min readPolitics
Purdue Pharma Filed For Bankruptcy. What Does It Mean For Lawsuits Against The Opioid Manufacturer?
Purdue Pharma filed for bankruptcy. What does it mean for lawsuits against the opioid manufacturer?